Transcriptions
Note: this content has been automatically generated.
00:00:00
question so as a clinician so what
00:00:06
should I do with the day turn out huh
00:00:09
yes so for the moment nothing so for the
00:00:12
moment this doesn't change of course
00:00:14
clinical practice we hope that one day
00:00:19
did this could change clinical practice
00:00:21
in let's say right now if i have an
00:00:25
infant with John this with severe
00:00:27
jaundice I go and look for genetic
00:00:30
defect in addition to antibodies of red
00:00:33
cells is what not think about many years
00:00:35
ago so the idea is to get a personalized
00:00:40
medicine but not in near future in the
00:00:43
future so maybe we will be able to
00:00:46
better understand why infection occurred
00:00:49
in each infant like we do for other
00:00:51
nettle diseases but not right now the
00:00:57
question do you have in long-term
00:01:03
follow-up data from some of these
00:01:04
patients do we have record and severe
00:01:07
infection later in life so for this to
00:01:11
patients the infant with get to with the
00:01:16
defecting get to had the treat infection
00:01:19
over one month so had the recurrence of
00:01:23
GBS infections or quite unusual feeling
00:01:26
that it's more or less one percent of
00:01:28
all Ruby strip infections and the other
00:01:33
one had a why also unusual phenotype
00:01:36
because had sepsis at five months of age
00:01:40
so was also quite an unusual phenotype
00:01:42
and additional follow-up in across eight
00:01:48
no I don't have this data but we will go
00:01:52
Richard this information
00:01:58
okay thank you very much so we move on